UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

Multiple sclerosis, 2008-06, Vol.14 (5), p.663-670

2008

Volltextzugriff (PDF)

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

The New England journal of medicine, 2008-10, Vol.359 (17), p.1786-1801

2008

Volltextzugriff (PDF)

Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?

Multiple sclerosis, 2009-08, Vol.15 (8), p.959-964

2009

Volltextzugriff (PDF)

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Annals of neurology, 2013-03, Vol.73 (3), p.327-340

2013

Volltextzugriff (PDF)

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Neurology, 2002-11, Vol.59 (10), p.1496

2002

Volltextzugriff (PDF)

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Lancet neurology, 2008-10, Vol.7 (10), p.903-914

2008

Volltextzugriff (PDF)

Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection

Neurology, 1992-02, Vol.42 (2), p.278-278

1992

Volltextzugriff (PDF)

Relapsing transverse myelitis

Neurology, 1991-05, Vol.41 (5), p.703-706

1991

Volltextzugriff (PDF)

Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study

Human brain mapping, 2015-10, Vol.36 (10), p.3749-3760

2015

Volltextzugriff (PDF)

Use of the Mechanical In-Exsufflator in Pediatric Patients With Neuromuscular Disease and Impaired Cough

Chest, 2004-04, Vol.125 (4), p.1406-1412

2004

Volltextzugriff (PDF)

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

Journal of the neurological sciences, 2010-05, Vol.292 (1), p.28-35

2010

Volltextzugriff (PDF)

Regional gray matter atrophy in relapsing remitting multiple sclerosis: Baseline analysis of multi-center data

Multiple sclerosis and related disorders, 2015-03, Vol.4 (2), p.124-136

2015

Volltextzugriff (PDF)

Systemic recombinant human interferon-β treatment of relapsing-remitting multiple sclerosis : pilot study analysis and six-year follow-up

Journal of interferon research, 1993-10, Vol.13 (5), p.333-340

1993

Volltextzugriff (PDF)

Chiari type I malformation in children and adolescents with cystic fibrosis

Pediatric pulmonology, 2000-12, Vol.30 (6), p.490-492

2000

Volltextzugriff (PDF)

Noninvasive measurement of the tension-time index in children with neuromuscular disease

Journal of applied physiology (1985), 2003-09, Vol.95 (3), p.931-937

2003

Volltextzugriff (PDF)

Effect of Sinus Surgery on Pulmonary Function in Patients With Cystic Fibrosis

The Laryngoscope, 1997-03, Vol.107 (3), p.328-331

1997

Volltextzugriff (PDF)

The treatment of subacute sclerosing panencephalitis with interferon: a case report

Journal of neurology, 1986-04, Vol.233 (2), p.102-107

1986

Volltextzugriff (PDF)

Progressive rubella panencephalitis. Late onset after congenital rubella

The New England journal of medicine, 1975-05, Vol.292 (19), p.990-993

1975

Volltextzugriff (PDF)

Purpuric rashes in cystic fibrosis

American journal of diseases of children (1960), 1989-09, Vol.143 (9), p.1030

1989

Volltextzugriff (PDF)

Brain stem tumors of childhood and adolescence

American journal of diseases of children (1960), 1970-06, Vol.119 (6), p.465

1970

Volltextzugriff (PDF)

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

Annals of neurology, 2009-10, Vol.66 (4), p.460-471

2009

Volltextzugriff (PDF)

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

Lancet neurology, 2008-09, Vol.7 (9), p.796-804

2008

Volltextzugriff (PDF)

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial

Neurology, 2008-07, Vol.71 (4), p.265-271

2008

Volltextzugriff (PDF)

Association of Socioeconomic Status with the Use of Chronic Therapies and Healthcare Utilization in Children with Cystic Fibrosis

The Journal of pediatrics, 2009-11, Vol.155 (5), p.634-639.e4

2009

Volltextzugriff (PDF)

Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families

Pediatric pulmonology, 2012-02, Vol.47 (2), p.144-152

2012

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

ThemaAdolescent

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(25)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Male
(23)
Adult
(22)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Neurosciences & Neurology
(14)
Clinical Neurology
(13)
Middle Aged
(13)
Neurology
(12)
Child
(9)
Treatment Outcome
(9)
Multiple Sclerosis
(7)
Child, Preschool
(6)
Magnetic Resonance Imaging
(6)
Multiple Sclerosis, Relapsing-Remitting - Pathology
(6)
Neurosciences
(6)

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial

Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection

Relapsing transverse myelitis

Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study

Use of the Mechanical In-Exsufflator in Pediatric Patients With Neuromuscular Disease and Impaired Cough

Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

Regional gray matter atrophy in relapsing remitting multiple sclerosis: Baseline analysis of multi-center data

Systemic recombinant human interferon-β treatment of relapsing-remitting multiple sclerosis : pilot study analysis and six-year follow-up

Chiari type I malformation in children and adolescents with cystic fibrosis

Noninvasive measurement of the tension-time index in children with neuromuscular disease

Effect of Sinus Surgery on Pulmonary Function in Patients With Cystic Fibrosis

The treatment of subacute sclerosing panencephalitis with interferon: a case report

Progressive rubella panencephalitis. Late onset after congenital rubella

Purpuric rashes in cystic fibrosis

Brain stem tumors of childhood and adolescence

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial

Association of Socioeconomic Status with the Use of Chronic Therapies and Healthcare Utilization in Children with Cystic Fibrosis

Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families

Aktive Filter

Suchergebnisse filtern